Want to see IN:SHK full AI Analyst Report?
SHK Stock Chart & Stats
₹140.10
₹7.61(5.41%)
At close: 4:00 PM EDT
₹140.10
₹7.61(5.41%)
Day’s Range― - ―
52-Week Range₹111.70 - ₹229.20
Previous CloseN/A
Volume897.53K
Average Volume (3M)19.83K
Market Cap
₹17.50B
Enterprise Value₹25.15B
Total Cash (Recent Filing)₹645.90M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)19.7
Beta1.77
Next Earnings
Nov 02, 2026Next Dividend Ex-DateN/A
Dividend Yield1.58%
Share Statistics
EPS (TTM)6.43
Shares Outstanding138,420,800
10 Day Avg. Volume10,689
30 Day Avg. Volume19,827
Financial Highlights & Ratios
PEG Ratio-3.85
Price to Book (P/B)1.14
Price to Sales (P/S)0.66
P/FCF Ratio293.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.5
Revenue Forecast (FY)₹26.87B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSteady revenue expansion indicates continued demand for SHK’s fragrances and flavors across its served markets. A growing revenue base can support operating scale, deepen customer relationships, and provide a foundation for recovery if margins improve over the next several quarters.
Diverse B2B End MarketsExposure to multiple recurring consumer-product categories gives SHK a broad demand base rather than dependence on one application. Its B2B formulation model can support repeat orders as customers continue producing everyday personal care, home care, food, and beverage products.
Serviceable Balance SheetModerate leverage and expanding equity provide a serviceable financial base for ongoing operations and investment. Although debt has risen, the stated leverage range is not excessive, giving SHK more flexibility than a highly indebted business if earnings remain under pressure.
Bears Say
Sharp Margin CompressionThe substantial decline in gross, operating, and net margins shows that higher revenue is currently producing much less profit. Unless pricing, costs, or product mix improve, this profitability reset can limit reinvestment, weaken earnings resilience, and reduce returns over the next several quarters.
Weak Free-Cash-Flow ConversionInconsistent free-cash-flow generation indicates that reported earnings are not translating reliably into cash available for debt reduction, investment, or shareholder returns. Persistently weak conversion can increase reliance on financing and make the company less flexible during periods of softer profitability.
Falling Returns With Higher DebtLower ROE alongside rising debt suggests that additional capital and assets are generating weaker earnings than in earlier years. This combination can reduce capital-allocation efficiency, increase financial pressure, and make a return to stronger shareholder economics dependent on operational improvement.
S H Kelkar and Company Ltd News
SHK FAQ
What was S H Kelkar and Company Ltd’s price range in the past 12 months?
S H Kelkar and Company Ltd lowest stock price was ₹111.70 and its highest was ₹229.20 in the past 12 months.
What is S H Kelkar and Company Ltd’s market cap?
S H Kelkar and Company Ltd’s market cap is ₹17.50B.
When is S H Kelkar and Company Ltd’s upcoming earnings report date?
S H Kelkar and Company Ltd’s upcoming earnings report date is Nov 02, 2026 which is in 6 days.
How were S H Kelkar and Company Ltd’s earnings last quarter?
S H Kelkar and Company Ltd released its earnings results on Jul 28, 2026. The company reported ₹1.8 earnings per share for the quarter, beating the consensus estimate of ₹1 by ₹0.8.
Is S H Kelkar and Company Ltd overvalued?
According to Wall Street analysts S H Kelkar and Company Ltd’s price is currently Overvalued.
Does S H Kelkar and Company Ltd pay dividends?
S H Kelkar and Company Ltd pays a Semiannually dividend of ₹1 which represents an annual dividend yield of 1.58%. See more information on S H Kelkar and Company Ltd dividends here
What is S H Kelkar and Company Ltd’s EPS estimate?
S H Kelkar and Company Ltd’s EPS estimate is 1.
How many shares outstanding does S H Kelkar and Company Ltd have?
S H Kelkar and Company Ltd has 138,420,800 shares outstanding.
What happened to S H Kelkar and Company Ltd’s price movement after its last earnings report?
S H Kelkar and Company Ltd reported an EPS of ₹1.8 in its last earnings report, beating expectations of ₹1. Following the earnings report the stock price went down -2.869%.
Which hedge fund is a major shareholder of S H Kelkar and Company Ltd?
Currently, no hedge funds are holding shares in IN:SHK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
S H Kelkar and Company Ltd
S H Kelkar and Company Limited, in conjunction with its subsidiary entities, functions as a principal producer and purveyor of aromatic compounds, flavorings, and various aroma ingredients, serving markets primarily in India and through exports. The company's fragrance offerings are incorporated into a broad spectrum of products, including those for personal hygiene, hair care, skin treatment, cosmetics, fabric conditioning, general household use, and high-end perfumes. Concurrently, its flavors are vital components in items such as dairy products, beverages, confectionery, baked goods, pharmaceuticals, nutraceuticals, and savory dishes. S H Kelkar markets its product lines through distinct brands like SHK, Cobra, and Keva, catering to a diverse customer base that spans major domestic and international Fast-Moving Consumer Goods (FMCG) corporations, alongside specialized blenders and manufacturers within the fragrance and flavor industries. The firm, established in 1914, is headquartered in Mumbai, India.
Technical Analysis
AVT Natural Products Limited
―
Camlin Fine Sciences Limited
―
Oriental Aromatics Ltd.
―
Privi Speciality Chemicals Limited
―
Rossari Biotech Ltd
―